Real-world survival outcomes of metastatic papillary and clear cell kidney cancer
In this study, real world data is used to compare [...]
ASCO GU 2021: Long-term follow-up of kidney cancer patients on nivolumab plus ipilimumab combination
Long-term follow-up data from the CheckMate-214 study of the nivolumab [...]
Patterns of metastases for clear cell, papillary and chromophobe RCC associated with survival
A recent study published in JAMA Network Open looked at [...]
Pembrolizumab as first-line treatment for kidney cancer
The recent phase II KEYNOTE-427 study investigated the efficacy and [...]
Immune-related adverse events from cabozantinib plus atezolizumab as first-line treatment for advanced kidney cancer
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
Inflammatory biomarkers for non-metastatic kidney cancer
This study looked at inflammatory biomarkers in the blood for [...]
ASCO 2020: Subtypes of kidney cancer differ in sites of metastases
A paper presented during the 2020 American Society of Clinical [...]
A potential biomarker for survival for non-metastatic kidney cancer
A recent study published in the journal International Urology and [...]
The most complete catalogue of clear cell renal cell carcinoma (ccRCC)
Researchers at the University of Texas (UT) Southwestern Medical Center [...]
Panobinostat plus everolimus not effective in metastatic kidney cancer
A recent phase I clinical trial assessed the combination of [...]
